SCD and cancer: However, dietary oleate cannot fully compensate for the lack of de novo SCD activity since both genetic and pharmacological inhibition of SCD in mice alters membrane lipid composition and are consequential in both normal physiology and pathology including cancer (12, 21, 25–28).